Statins and venous thrombosis: a story too good to be true?
- PMID: 23028262
- PMCID: PMC3445443
- DOI: 10.1371/journal.pmed.1001311
Statins and venous thrombosis: a story too good to be true?
Abstract
Frits Rosendaal comments on new findings from a meta-analysis conducted by Kazem Rahimi and colleagues, evaluating whether statins can prevent venous thromboembolism.
Conflict of interest statement
The author reports no competing interests in relation to statins. The author is named on several patents for prothrombotic gene variants (such as Factor V Leiden) but does not benefit personally from royalties on these.
Comment on
-
Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.PLoS Med. 2012;9(9):e1001310. doi: 10.1371/journal.pmed.1001310. Epub 2012 Sep 18. PLoS Med. 2012. PMID: 23028261 Free PMC article.
References
-
- Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, et al. (2012) Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med 9: e1001310 doi:10.1371/journal.pmed.1001310. - DOI - PMC - PubMed
-
- Rosendaal FR (1999) Risk factors for venous thrombotic disease. Thromb Haemost 82: 610–619. - PubMed
-
- Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, et al. (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5: 692–699. - PubMed
-
- Baglin T, Luddington R, Brown K, Baglin C (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362: 523–526. - PubMed
-
- Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293: 2352–2361. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
